Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - omalizumab
Get the latest updates from Google Alert - omalizumab directly as they happen.
Follow now 111 followers
Latest posts
Last updated about 5 hours ago
CSU Educational Pilot Shows Drug Access a Major Hurdle | AJMC
about 15 hours ago
Access to biologic therapy, such as omalizumab, is a significant barrier for...
View of Efficacy of omalizumab in the management of moderate-to-severe asthma in ...
about 16 hours ago
... omalizumab in the management of moderate-to-severe asthma in paediatric patients: a...
Efficacy of omalizumab in the management of moderate-to-severe asthma in paediatric patients
about 16 hours ago
Omalizumab, Allergic asthma, Chronic sinusitis, Pediatric allergy, Quality of life, Biologic therapy...
Dupilumab vs Omalizumab in Patients w/ Chronic Rhinosinusitis w - YouTube
about 18 hours ago
... Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting...
Omalizumab Biosimilars Market Analysis Report: Global Insights By Region, Type (150 mg ...
about 23 hours ago
New Jersey, USA - Omalizumab Biosimilars market is estimated to reach USD...
Celltrion launches autoimmune disease drug Avtozma in major European markets | - KBR
1 day ago
Currently, clinical trials are underway for Steqeyma (ustekinumab) and Omlyclo (omalizumab), and...
Celltrion Launches 'Aptozma' in Three European Countries... Secures 80% of French Private ...
1 day ago
These studies, currently underway for Stekima (ingredient: ustekinumab) and Omriclo (ingredient: omalizumab)...
New Research: Case Series: Combination of dupilumab and omalizumab as a way to ...
1 day ago
New Research: Case Series: Combination of dupilumab and omalizumab as a way...
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria
1 day ago
Background: There is currently no accepted biomarker for predicting which patients will...
January 2026 Product Updates | Pharmacy Times
1 day ago
Omalizumab-igec (Omlyclo). From: Celltrion USA. The FDA approved a new 300-mg/2-mL prefilled...
标准化压力激发试验作为奥马珠单抗治疗延迟性压力性荨麻疹客观临床标志物的真实世界前瞻 ...
1 day ago
本文通过标准化皮肤压力计（dermographometer）激发试验，前瞻性证实奥马珠单抗（omalizumab）在抗组胺药难治性延迟性压力性荨麻疹（DPU）中具有快速（24-48 ...
Celltrion Wins Health Canada Approval for New High-Dose OMLYCLO Formats
1 day ago
... omalizumab biosimilar used to treat chronic spontaneous urticaria.The ... omalizumab biosimilar...